Comparison

TAK-632 European Partner

Item no. TMO-T1886-200mg
Manufacturer TargetMol
CASRN 1228591-30-7
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 20 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,9927
Citations 1. Zhang Q, et al. EMBO Mol Med. 2012 Apr; 4(4): 298-312.
Smiles Fc1ccc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2C#N)cc1NC(=O)Cc1cccc(c1)C(F)(F)F
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Aurora Kinase inhibitor,FGFR inhibitor,PDGFR inhibitor,Raf inhibitor
Shipping Condition Cool pack
Available
Manufacturer - Targets
PDGFR|||Raf|||FGFR|||Aurora Kinase
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
554.52
Description
TAK-632, a potent pan-Raf inhibitor (GenScript, 2020), is characterized by its molecular weight [M] for [C 22 H 19 FN 2 O 2] of 362.4 by LC-MS, with a purity of 99% (HPLC). The compound exhibits white to off-white solid form and has a melting point [M] ranging from 178°C to 182°C (GenScript, 2020). Its solubility profile includes DMSO, in which it is soluble to 100mM (GenScript, 2020).
Pathways
Tyrosine Kinase/Adaptors|||Chromatin/Epigenetic|||Cell Cycle/Checkpoint|||Angiogenesis|||MAPK

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close